Published in Anticancer Res on June 01, 2013
EGFR inhibition induces proinflammatory cytokines via NOX4 in HNSCC. Mol Cancer Res (2013) 0.97
Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis. Onco Targets Ther (2014) 0.93
Hyperdynamic left ventricular ejection fraction in the intensive care unit. Crit Care (2015) 0.82
Erlotinib augmentation with dapsone for rash mitigation and increased anti-cancer effectiveness. Springerplus (2015) 0.76
Ginseng Purified Dry Extract, BST204, Improved Cancer Chemotherapy-Related Fatigue and Toxicity in Mice. Evid Based Complement Alternat Med (2015) 0.75
Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet (2009) 6.92
The cost-effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of brain metastasis in Vietnam from the perspective of patients and families. World Neurosurg (2011) 1.44
Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer. Cancer Res (2003) 1.44
Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data. Cochrane Database Syst Rev (2009) 1.26
Cytokines in head and neck cancer. Cytokine Growth Factor Rev (2006) 1.24
Long-term radiation sequelae after breast-conserving therapy in women with early-stage breast cancer: an observational study using the LENT-SOMA scoring system. Int J Radiat Oncol Biol Phys (2003) 1.11
Is there a life-long risk of brachial plexopathy after radiotherapy of supraclavicular lymph nodes in breast cancer patients? Radiother Oncol (2004) 1.09
Association of single nucleotide polymorphisms in ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with clinical and cellular radiosensitivity. Radiother Oncol (2010) 1.08
B cells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cells. Blood (2002) 1.08
Radiotherapy for symptomatic vertebral hemangiomas: results of a multicenter study and literature review. Int J Radiat Oncol Biol Phys (2009) 1.07
Tumor-specific glycosylation of the carcinoma-associated epithelial cell adhesion molecule EpCAM in head and neck carcinomas. Cancer Lett (2003) 1.06
Prognostic factors for outcomes after whole-brain irradiation of brain metastases from relatively radioresistant tumors: a retrospective analysis. BMC Cancer (2010) 1.06
Connections are clearly more complexy. Dtsch Arztebl Int (2013) 1.06
Glandular tissue from human pancreas and salivary gland yields similar stem cell populations. Eur J Cell Biol (2009) 1.06
Isolation and characterization of adult stem cells from human salivary glands. Stem Cells Dev (2008) 1.05
Palliative radiotherapy--new approaches. Semin Oncol (2011) 1.02
A case of central sleep apnea strictly dependent upon REM-sleep. J Neurol (2010) 1.02
Role of cytokines in head and neck squamous cell carcinoma. Expert Rev Anticancer Ther (2006) 1.01
Application of the Vibrant Soundbridge to unilateral osseous atresia cases. Laryngoscope (2009) 1.01
Central neurocytoma: a multi-disciplinary review. Br J Neurosurg (2009) 0.98
Analysis of plasmacytoid and myeloid dendritic cells in nasal epithelium. Clin Vaccine Immunol (2006) 0.97
The effect of amifostine or IMRT to preserve the parotid function after radiotherapy of the head and neck region measured by quantitative salivary gland scintigraphy. Radiother Oncol (2008) 0.97
Allogenic antibody-mediated identification of head and neck cancer antigens. Biochem Biophys Res Commun (2004) 0.96
Innate signaling in otitis media: pathogenesis and recovery. Curr Allergy Asthma Rep (2011) 0.96
Human ceruminous gland: ultrastructure and histochemical analysis of antimicrobial and cytoskeletal components. Anat Rec A Discov Mol Cell Evol Biol (2006) 0.96
Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck. Strahlenther Onkol (2009) 0.95
The role of DNA sensing and innate immune receptor TLR9 in otitis media. Innate Immun (2011) 0.94
Stem cells in squamous head and neck cancer. Crit Rev Oncol Hematol (2011) 0.94
Comparison of electron IMRT to helical photon IMRT and conventional photon irradiation for treatment of breast and chest wall tumours. Radiother Oncol (2010) 0.94
Health-related quality of life in long term breast cancer survivors treated with breast conserving therapy: impact of age at therapy. Breast Cancer Res Treat (2005) 0.93
Potential stem cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer. In Vivo (2008) 0.93
Permanent up-regulation of regulatory T-lymphocytes in patients with head and neck cancer. Int J Mol Med (2010) 0.93
Application of the Vibrant Soundbridge in bilateral congenital atresia in toddlers. Acta Otolaryngol (2010) 0.91
Tumour-derived prostaglandin E and transforming growth factor-beta synergize to inhibit plasmacytoid dendritic cell-derived interferon-alpha. Immunology (2009) 0.90
The Lübeck flowchart for functional and aesthetic rehabilitation of aural atresia and microtia. Otol Neurotol (2012) 0.90
Impaired monocyte function in cancer patients: restoration with a cyclooxygenase-2 inhibitor. FASEB J (2002) 0.89
Decreased levels of circulating regulatory NK cells in patients with head and neck cancer throughout all tumor stages. Anticancer Res (2009) 0.89
Cytokeratin 8 associates with the external leaflet of plasma membranes in tumour cells. Biochem Biophys Res Commun (2005) 0.89
A new score predicting the survival of patients with spinal cord compression from myeloma. BMC Cancer (2012) 0.89
The Oral Serine Protease Inhibitor WX-671 - First Experience in Patients with Advanced Head and Neck Carcinoma. Breast Care (Basel) (2008) 0.87
Increased cytokine secretion in head and neck cancer upon p38 mitogen-activated protein kinase activation. Int J Mol Med (2007) 0.86
Yeast Gcn4p stabilization is initiated by the dissociation of the nuclear Pho85p/Pcl5p complex. Mol Biol Cell (2006) 0.86
Inflammatory pseudotumor of the hypopharynx: clinical diagnosis, immunohistochemical findings and treatment of this rare disease. In Vivo (2009) 0.86
Prognostic factors for different outcomes in patients with metastatic spinal cord compression from cancer of unknown primary. BMC Cancer (2012) 0.86
Pharmacological prevention of radiation-induced dry eye-an experimental study in a rabbit model. Graefes Arch Clin Exp Ophthalmol (2007) 0.85
Sleep apnoea in patients after treatment of head neck cancer. Acta Otolaryngol (2009) 0.84
Dose escalation in patients receiving whole-brain radiotherapy for brain metastases from colorectal cancer. Strahlenther Onkol (2010) 0.84
Effects of irradiation and cisplatin on human glioma spheroids: inhibition of cell proliferation and cell migration. J Cancer Res Clin Oncol (2005) 0.84
Metastases of squamous cell carcinoma of the head and neck show increased levels of nucleotide excision repair protein XPF in vivo that correlate with increased chemoresistance ex vivo. Int J Oncol (2010) 0.84
Induction of c-Myc-dependent cell proliferation through toll-like receptor 3 in head and neck cancer. Int J Mol Med (2008) 0.84
Comparing the cost-effectiveness of two brain metastasis treatment modalities from a payer's perspective: stereotactic radiosurgery versus surgical resection. Clin Neurol Neurosurg (2012) 0.83
Functional characterization of novel mutations affecting survivin (BIRC5)-mediated therapy resistance in head and neck cancer patients. Hum Mutat (2012) 0.83
Characterization of spontaneous and TGF-β-induced cell motility of primary human normal and neoplastic mammary cells in vitro using novel real-time technology. PLoS One (2013) 0.83
Secretion of tumor-promoting and immune suppressive cytokines by cell lines of head and neck squamous cell carcinoma. In Vivo (2006) 0.83
Established and novel NF-κB inhibitors lead to downregulation of TLR3 and the proliferation and cytokine secretion in HNSCC. Oral Oncol (2011) 0.83
Activated B cells mediate efficient expansion of rare antigen-specific T cells. Hum Immunol (2007) 0.83
LPS-induced mucin expression in human sinus mucosa can be attenuated by hCLCA inhibitors. J Endotoxin Res (2007) 0.82
The inhibition of proliferation and migration of glioma spheroids exposed to temozolomide is less than additive if combined with irradiation. Oncol Rep (2007) 0.82
Head and neck cancer triggers increased IL-6 production of CD34+ stem cells from human cord blood. In Vivo (2007) 0.82
mTOR inhibitors show promising in vitro activity in bladder cancer and head and neck squamous cell carcinoma. Oncol Rep (2011) 0.82
Number of involved extracranial organs predicts survival in patients with brain metastasis from small cell lung cancer. Anticancer Res (2013) 0.81
Radioprotective effect of lidocaine on function and ultrastructure of salivary glands receiving fractionated radiation. Int J Radiat Oncol Biol Phys (2012) 0.81
Cartilage tissue engineering using resorbable scaffolds. J Tissue Eng Regen Med (2008) 0.81
Phosphorylation of STAT3 in head and neck cancer requires p38 MAPKinase, whereas phosphorylation of STAT1 occurs via a different signaling pathway. Anticancer Res (2011) 0.81
Late effects and cosmetic results of conventional versus hypofractionated irradiation in breast-conserving therapy. Strahlenther Onkol (2005) 0.81
Toll-like receptor modulation in head and neck cancer. Crit Rev Immunol (2008) 0.80
Radiotherapy for oligometastatic disease in patients with spinal cord compression (MSCC) from relatively radioresistant tumors. Strahlenther Onkol (2010) 0.80
Functional alteration of myeloid dendritic cells through head and neck cancer. Anticancer Res (2007) 0.80
Application methods of local anaesthetic infiltrations for postoperative pain relief in tonsillectomy: a prospective, randomised, double-blind, clinical trial. Eur Arch Otorhinolaryngol (2009) 0.80
Characterisation of gp34, a GPI-anchored protein expressed by schizonts of Theileria parva and T. annulata. Mol Biochem Parasitol (2010) 0.79
Grading system for the selection of patients with congenital aural atresia for active middle ear implants. Neuroradiology (2013) 0.79
Effect of dexamethasone and ACC on bacteria-induced mucin expression in human airway mucosa. Am J Respir Cell Mol Biol (2007) 0.79
Dexamethasone and N-acetyl-cysteine attenuate Pseudomonas aeruginosa-induced mucus expression in human airways. Pulm Pharmacol Ther (2010) 0.79
Isolation of human myeloid dendritic cells from tumor tissue and peripheral blood. In Vivo (2006) 0.79
A novel xenogeneic co-culture system to examine neuronal differentiation capability of various adult human stem cells. PLoS One (2011) 0.79
Increased phosphorylation of STAT5b, but not STAT5a, in nasal polyps. Am J Rhinol Allergy (2015) 0.79
Expression of Wnt-1, TGF-β and related cell-cell adhesion components following radiotherapy in salivary glands of patients with manifested radiogenic xerostomia. Radiother Oncol (2011) 0.79
Generation of an autologous cell system for immunotherapy of squamous cell carcinoma of the head and neck. Anticancer Res (2005) 0.79
Biodistribution and radioimmunotherapy of SCCHN in xenotransplantated SCID mice with a 131I-labelled anti-EpCAM monoclonal antibody. Anticancer Res (2007) 0.79
Comparison of two different local anaesthetic infiltrations for postoperative pain relief in tonsillectomy: a prospective, randomised, double blind, clinical trial. Eur Arch Otorhinolaryngol (2010) 0.78
Polyadenylation of rRNA- and tRNA-based yeast transcripts cleaved by internal ribozyme activity. Curr Genet (2003) 0.78
Immune restoration in head and neck cancer patients after in vivo COX-2 inhibition. Cancer Immunol Immunother (2007) 0.78
Prevalence of targetable oncogenic mutations and genomic alterations in Epstein-Barr virus-associated diffuse large B-cell lymphoma of the elderly. Leuk Lymphoma (2014) 0.78
Radiotherapeutic Options for Symptom Control in Breast Cancer. Breast Care (Basel) (2011) 0.78
Head and neck cancer triggers the internalization of TLR3 in natural killer cells. Int J Mol Med (2007) 0.78
Human mesenchymal stromal cells from adipose tissue of the neck. Eur Arch Otorhinolaryngol (2012) 0.78